Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement

PURPOSE: We conducted a phase I study of hepatic arterial infusion (HAI) cisplatin and systemic chemotherapy in patients with advanced cancer and dominant liver involvement. METHODS: Patients were treated with HAI cisplatin 100–125 mg/m(2) (and 3,000 IU heparin) intraarterially and liposomal doxorub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tsimberidou, Apostolia M., Moulder, Stacy, Fu, Siqing, Wen, Sijin, Naing, Aung, Bedikian, Agop Y., Daring, Shawn, Uehara, Cynthia, Ng, Chaan, Wallace, Michael, Camacho, Luis, Kurzrock, Razelle
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410638/
https://ncbi.nlm.nih.gov/pubmed/20204368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1266-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge